EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aromatase inhibitors beyond hormone-dependent cancers: Mechanisms, preclinical evidence, and emerging clinical applications

Angelo Meoli, Ruslana Mollo, Joanna Kopecka, Simona Saponara, Chiara Riganti

Cancer Letters · 2027-01 · 664 · 218971

DOI: 10.1016/j.canlet.2026.218971 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2027-01. Verfasst von Angelo Meoli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Torino, Piazza Nizza 44, 10126, Torino, Italy; Molecular Biotechnology Center "Guido Tarone", Piazza Nizza 44, …. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guido Berlucchi Foundation, AIRC Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Aromatase inhibitorsClinical applicationsDrug repurposingEstrogen signalingMolecular mechanismNon–hormone-dependent tumorsPreclinical evidence

Autor:innen und Institutionen

  • Department of Oncology, University of Torino, Piazza Nizza 44, 10126, Torino, Italy; Molecular Biotechnology Center "Guido Tarone", Piazza Nizza 44, 10126, Torino, Italy. Electronic address: angelo.meoli@unito.it.
  • Department of Oncology, University of Torino, Piazza Nizza 44, 10126, Torino, Italy; Molecular Biotechnology Center "Guido Tarone", Piazza Nizza 44, 10126, Torino, Italy. Electronic address: ruslana.mollo@unito.it.
  • Department of Oncology, University of Torino, Piazza Nizza 44, 10126, Torino, Italy; Molecular Biotechnology Center "Guido Tarone", Piazza Nizza 44, 10126, Torino, Italy. Electronic address: joanna.kopecka@unito.it.
  • Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy. Electronic address: simona.saponara@unisi.it.
  • Department of Oncology, University of Torino, Piazza Nizza 44, 10126, Torino, Italy; Molecular Biotechnology Center "Guido Tarone", Piazza Nizza 44, 10126, Torino, Italy. Electronic address: chiara.riganti@unito.it.

Förderung

  • Guido Berlucchi Foundation
  • AIRC Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Meoli, A., Mollo, R., Kopecka, J., Saponara, S., & Riganti, C. (2027). Aromatase inhibitors beyond hormone-dependent cancers: Mechanisms, preclinical evidence, and emerging clinical applications. Cancer Letters, 664, 218971. https://doi.org/10.1016/j.canlet.2026.218971

Vancouver

Meoli A, Mollo R, Kopecka J, Saponara S, Riganti C. Aromatase inhibitors beyond hormone-dependent cancers: Mechanisms, preclinical evidence, and emerging clinical applications. Cancer Letters. 2027;664:218971. doi:10.1016/j.canlet.2026.218971

BibTeX
@article{Meoli2027,
  author = {Meoli, Angelo and Mollo, Ruslana and Kopecka, Joanna and Saponara, Simona and Riganti, Chiara},
  title = {Aromatase inhibitors beyond hormone-dependent cancers: Mechanisms, preclinical evidence, and emerging clinical applications},
  journal = {Cancer Letters},
  year = {2027},
  volume = {664},
  pages = {218971},
  doi = {10.1016/j.canlet.2026.218971}
}
Kostenlos starten →